A-25 Paced Auditory Serial Addition Test in Individuals with Cocaine Versus Methamphetamine Dependence

Archives of Clinical Neuropsychology 34 (2019) 860–1099 Abstract Poster Session A NEUROPSYCHOLOGICAL DOMAINS: EXECUTIVE FUNCTIONS A-25 Paced Auditory Serial Addition Test in Individuals with Cocaine Versus Methamphetamine Dependence Pollard A, Hauson A, Stelmach N, Sarkissians S, Walker A, Cabral C, Wollman S, Hall M Objective: Research suggests that cocaine and methamphetamine differ in their impact on executive functions (EF). The Paced Auditory Serial Addition Test (PASAT) is used to assess working memory; a component of EF. The purpose of this meta-analysis was to examine the difference between the effect of these two drugs on PASAT scores. Data Selection: Three researchers independently searched nine databases (e.g., PsycINFO, Pubmed, ProceedingsFirst), extracted required data, and calculated effect sizes. Inclusion criteria identified studies that had (a) compared cocaine or methamphetamine dependent groups to healthy controls and (b) matched groups on either age, education, or IQ (at least 2 out of 3). Studies were excluded if participants were reported to have Axis I diagnoses (other than cocaine or methamphetamine dependence) or comorbidities known to impact neuropsychological functioning. Six articles were coded and analyzed for the current study. Data Synthesis: Cocaine studies showed a medium statistically significant effect size (g = 0.370, p = 0.020), while methamphetamine did not (g = 0.198, p = 0.172). There was no heterogeneity in effect sizes for both drugs. Subgroup analysis found no significant difference between the two drugs on the PASAT (Q-between = 0.646, p = 0.421). Conclusions: In contrast to methamphetamine, cocaine is associated with poorer performance on PASAT. This is in line with previous studies that found that cocaine had more significant impact on EF than methamphetamine. Given the preliminary nature of this meta-analysis and the small number of studies on the topic, future primary studies should directly contrast how these two drugs impact EF. © The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: . doi:10.1093/arclin/acz034.25 Wednesday, November 13, 2019 5:30 pm – 7:00 pm  (...truncated)